Marianna P et al. |
Valproic acid, trichostatin and their combination with hemin preferentially enhance gamma-globin gene expression in human erythroid liquid cultures. |
2001 |
Haematologica |
pmid:11454524
|
Cho JH et al. |
DNA methylation regulates placental lactogen I gene expression. |
2001 |
Endocrinology |
pmid:11459782
|
Franco PJ et al. |
The orphan nuclear receptor TR2 interacts directly with both class I and class II histone deacetylases. |
2001 |
Mol. Endocrinol. |
pmid:11463856
|
Sutherland JE et al. |
The histone deacetylase inhibitor trichostatin A reduces nickel-induced gene silencing in yeast and mammalian cells. |
2001 |
Mutat. Res. |
pmid:11470494
|
Phiel CJ et al. |
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. |
2001 |
J. Biol. Chem. |
pmid:11473107
|
Sundqvist A et al. |
Functional knockout of the corepressor CtBP by the second exon of adenovirus E1a relieves repression of transcription. |
2001 |
Exp. Cell Res. |
pmid:11478854
|
Jacob AL et al. |
Acetylation of steroidogenic factor 1 protein regulates its transcriptional activity and recruits the coactivator GCN5. |
2001 |
J. Biol. Chem. |
pmid:11479297
|
Bovenzi V and Momparler RL |
Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. |
2001 |
Cancer Chemother. Pharmacol. |
pmid:11488527
|
Walker GE et al. |
Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex. |
2001 |
Endocrinology |
pmid:11517158
|
Jorgensen JS and Nilson JH |
AR suppresses transcription of the alpha glycoprotein hormone subunit gene through protein-protein interactions with cJun and activation transcription factor 2. |
2001 |
Mol. Endocrinol. |
pmid:11518798
|
Benjamin D and Jost JP |
Reversal of methylation-mediated repression with short-chain fatty acids: evidence for an additional mechanism to histone deacetylation. |
2001 |
Nucleic Acids Res. |
pmid:11522830
|
Amann JM et al. |
ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. |
2001 |
Mol. Cell. Biol. |
pmid:11533236
|
Osborne A et al. |
Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation. |
2001 |
Mol. Cell. Biol. |
pmid:11533238
|
Plant KE et al. |
Intergenic transcription in the human beta-globin gene cluster. |
2001 |
Mol. Cell. Biol. |
pmid:11533239
|
Chen Lf W et al. |
Duration of nuclear NF-kappaB action regulated by reversible acetylation. |
2001 |
Science |
pmid:11533489
|
Vinatzer U et al. |
The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase. |
2001 |
Br. J. Haematol. |
pmid:11552981
|
Sekimata M et al. |
Involvement of a novel zinc finger protein, MIZF, in transcriptional repression by interacting with a methyl-CpG-binding protein, MBD2. |
2001 |
J. Biol. Chem. |
pmid:11553631
|
Deltour S et al. |
Characterization of HRG22, a human homologue of the putative tumor suppressor gene HIC1. |
2001 |
Biochem. Biophys. Res. Commun. |
pmid:11554746
|
Kiela PR et al. |
Regulation of the rat NHE3 gene promoter by sodium butyrate. |
2001 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:11557515
|
Jung M |
Inhibitors of histone deacetylase as new anticancer agents. |
2001 |
Curr. Med. Chem. |
pmid:11562279
|